These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34351802)

  • 1. The Drama of Wallerian Degeneration: The Cast, Crew, and Script.
    Zhang K; Jiang M; Fang Y
    Annu Rev Genet; 2021 Nov; 55():93-113. PubMed ID: 34351802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wallerian degeneration: an emerging axon death pathway linking injury and disease.
    Conforti L; Gilley J; Coleman MP
    Nat Rev Neurosci; 2014 Jun; 15(6):394-409. PubMed ID: 24840802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves.
    Beirowski B; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
    BMC Neurosci; 2005 Feb; 6():6. PubMed ID: 15686598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death Receptor 6 Promotes Wallerian Degeneration in Peripheral Axons.
    Gamage KK; Cheng I; Park RE; Karim MS; Edamura K; Hughes C; Spano AJ; Erisir A; Deppmann CD
    Curr Biol; 2017 Mar; 27(6):890-896. PubMed ID: 28285993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system.
    Coleman MP; Ribchester RR
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):227-38. PubMed ID: 15180483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of SIRPα (signal regulatory protein-α) promotes phagocytic clearance of myelin debris in Wallerian degeneration, axon regeneration, and recovery from nerve injury.
    Elberg G; Liraz-Zaltsman S; Reichert F; Matozaki T; Tal M; Rotshenker S
    J Neuroinflammation; 2019 Dec; 16(1):277. PubMed ID: 31883525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
    Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
    Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wallerian degeneration, wld(s), and nmnat.
    Coleman MP; Freeman MR
    Annu Rev Neurosci; 2010; 33():245-67. PubMed ID: 20345246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Of axons that struggle to make ends meet: Linking axonal bioenergetic failure to programmed axon degeneration.
    Babetto E; Beirowski B
    Biochim Biophys Acta Bioenerg; 2022 Jun; 1863(5):148545. PubMed ID: 35339437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of degenerative spheroids after injury.
    Yong Y; Gamage K; Cushman C; Spano A; Deppmann C
    Sci Rep; 2020 Sep; 10(1):15472. PubMed ID: 32963272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD
    Alexandris AS; Koliatsos VE
    Antioxid Redox Signal; 2023 Dec; 39(16-18):1167-1184. PubMed ID: 37503611
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of injury-induced axon degeneration.
    Ding C; Hammarlund M
    Curr Opin Neurobiol; 2019 Aug; 57():171-178. PubMed ID: 31071521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
    Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L
    Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarm1 Deletion, but Not Wld
    Gilley J; Ribchester RR; Coleman MP
    Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARM1-mediated wallerian degeneration: A possible mechanism underlying organophosphorus-induced delayed neuropathy.
    Song M; Kang K; Song F
    Med Hypotheses; 2021 Oct; 155():110666. PubMed ID: 34455132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The axon degeneration gene SARM1 is evolutionarily distinct from other TIR domain-containing proteins.
    Malapati H; Millen SM; J Buchser W
    Mol Genet Genomics; 2017 Aug; 292(4):909-922. PubMed ID: 28447196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling mechanisms regulating Wallerian degeneration.
    Freeman MR
    Curr Opin Neurobiol; 2014 Aug; 27():224-31. PubMed ID: 24907513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.